These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. High concentrations of interleukin-8 and monocyte chemoattractant protein-1 in urine of patients with acute Kawasaki disease. Jibiki T; Terai M; Kohno Y Eur J Pediatr; 2004 Dec; 163(12):749-50. PubMed ID: 15365828 [No Abstract] [Full Text] [Related]
67. The link between Kawasaki disease shock syndrome and macrophage activation syndrome in terms of organ dysfunction observed in children with systemic inflammatory response syndrome. Han SB; Lee SY Paediatr Int Child Health; 2018 Nov; 38(4):308-309. PubMed ID: 30253701 [No Abstract] [Full Text] [Related]
68. Should refractory Kawasaki disease be considered occult macrophage activation syndrome? Choi UY; Han SB; Lee SY; Jeong DC Semin Arthritis Rheum; 2017 Feb; 46(4):e17. PubMed ID: 27639924 [No Abstract] [Full Text] [Related]
69. An evaluation of the validity of the animal models of Kawasaki disease vasculopathy. Orenstein JM; Rowley AH Ultrastruct Pathol; 2014 Aug; 38(4):245-7. PubMed ID: 25054804 [No Abstract] [Full Text] [Related]
71. Acute kidney injury occurs only rarely in patients with Kawasaki disease. Watanabe T; Abe T; Tsukano S Pediatr Res; 2017 Dec; 82(6):890-891. PubMed ID: 28817559 [No Abstract] [Full Text] [Related]
72. Response to "Acute kidney injury occurs only rarely in patients with Kawasaki disease". Chuang GT; Chang LY Pediatr Res; 2017 Dec; 82(6):892. PubMed ID: 28880860 [No Abstract] [Full Text] [Related]
73. [Exploration of immune system by single cell sequencing and its application in Kawasaki disease]. Lin QP; Xie LJ Zhonghua Er Ke Za Zhi; 2023 Mar; 61(3):282-285. PubMed ID: 36849361 [TBL] [Abstract][Full Text] [Related]
74. Balancing Value and Risk in Early Discharge of Patients With Kawasaki Disease. Money NM; Darby JB Hosp Pediatr; 2019 Oct; 9(10):824-826. PubMed ID: 31548263 [No Abstract] [Full Text] [Related]
75. Kawasaki disease in Campbelltown, a suburban hospital. Edwards M; Tinoco-Mendoza G; Tovmassian D; Ling T; Teh JR; Ong C; Mudgil P; Whitehall J J Paediatr Child Health; 2015 Apr; 51(4):466-7. PubMed ID: 25828186 [No Abstract] [Full Text] [Related]
76. Kawasaki disease: what the paediatrician needs to know. Ritz N Eur J Pediatr; 2017 Aug; 176(8):1011. PubMed ID: 28656473 [No Abstract] [Full Text] [Related]
77. Role of Inflammasomes in Kawasaki Disease. Gupta A Indian J Pediatr; 2023 Jan; 90(1):5-6. PubMed ID: 36151364 [No Abstract] [Full Text] [Related]
78. Clinical features of Kawasaki disease initially mimicking retropharyngeal abscess: a retrospective analysis. Chen YC; Pan HG; Jia DS; Wang HC; Li L; Teng YS Pediatr Rheumatol Online J; 2022 Dec; 20(1):115. PubMed ID: 36514104 [TBL] [Abstract][Full Text] [Related]
79. Evolution of laboratory values in patients with Kawasaki disease. Tremoulet AH; Jain S; Chandrasekar D; Sun X; Sato Y; Burns JC Pediatr Infect Dis J; 2011 Dec; 30(12):1022-6. PubMed ID: 21817952 [TBL] [Abstract][Full Text] [Related]
80. Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population. Ban JY; Yoon KL; Kim SK; Kang S; Chung JH Pediatr Cardiol; 2009 Apr; 30(3):331-5. PubMed ID: 19048177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]